Pharma Industry News
Printable Version   Email to a friend

Star Anise Spice: New Treatment for Bird Flu?

November 30, 2005

Tamiflu (oseltamivir) may have a new rival. Star anise, a licorice-flavored spice that is a staple of many Asian kitchens, may be a new weapon in the arsenal to fight global influenza.

A key ingredient in Chinese cuisine's five-spice powder, star anise is also the primary source of shikimic acid used to produce oseltamivir phosphate-sold under brand-name Tamiflu-according to a report by National Geographic.

Rising fears of a bird-flu pandemic have raised not only demand for Tamiflu, but also demand for the once-obscure fruit from which it is produced. This month, English-language newspaper China Daily reported that the price of star anise in some Chinese markets had doubled in just one week's time.

Apparently, the US spice market is also seeing spikes in star anise prices. "This week it has jumped considerably in price, and now supply issues are becoming a problem as well, when a month ago there was plenty of supply," said Dennis Knock of Frontier Natural Foods Co-Op in Norway, Iowa, according to National Geographic.

The news may not be good for Roche, the Swiss pharmaceutical company that is currently the sole producer of Tamiflu. Tamiflu's revenues more than doubled from the three-month period ending in June to the three-month period ending in September 2005, when Tamiflu garnered sales of US$211 million, according to National Geographic.

And Roche plans to produce around 300 million doses of Tamiflu by 2007; this year, it will produce about 55 million doses.

Tamiflu or Mu Shu Pork?

The media coverage around Tamiflu has contributed to the stir about star anise.

"There has been a lot of emotional run-up in prices, both in China and in the US," explained Ed Deep, a spice broker with AA Sayia & Company in Hoboken, New Jersey, to National Geographic. "In New York it has gone from around $1.30 a pound [about half a kilogram] up to $1.70 a pound."

"[Roche] is buying a larger amount of star anise to extract the shikimic acid that they need for Tamiflu," he added. He noted that some demand is being driven by "people who believe that star anise will help with the flu-which we believe is erroneous."

Chinese cooks are also fueling star anise price-spikes, according to Deep.

"I was in China last week, and almost every day there was some report on star anise being used [to fight flu], and the local markets are revved up," he said.

"Mostly it's because housewives and people who use this in cooking think that if pharmaceutical companies are buying all of this up, there won't be enough to make their mu shu pork."

Why Star Anise Won't Work

In its original form as a spice, star anise offers little or no help to flu sufferers. Shikimic acid is extracted from the fruit's distinctive seedpod only by a lengthy and complicated process-and the details are Roche's trade-secret.

Even Chinese medical practitioners advise consumers not to bother stockpiling star anise as a protection against the flu.

However, the plant still has some medicinal uses.

"It's used as a digestive stimulant in Chinese medicine," said Bryn Clark, an herbalist practicing in Beverly, Massachusetts. "It's got a warming quality, so it has kind of a slightly stimulant effect on a digestive system that has gotten slow or is having problems."

Star anise teas are also used to treat colic in babies. However, in 2003, the US Food and Drug Administration (FDA) issued an advisory against using such teas when dozens of people became ill after drinking them. The reason may be that these teas in question contained a different variety of star anise. (Japanese star anise is toxic, whereas its benign Chinese relative is benign).

Nevertheless, the FDA warned against consuming any star anise teas, citing the lack of specific evidence to support their assumed benefits.

Harvesting Star Anise

Star anise grows on evergreen trees in hot, humid, mountainous areas and thrive well in China's southwestern provinces of Guizhou, Guangxi Zhuangzu, Sichuan and Yunnan.

The eight-pointed seedpods are harvested and dried before Roche begins the extraction process to yield shikimic acid for Tamiflu. For every 66 pounds (30 kilograms) of pods, only 2.2 pounds (1 kilogram) of shikimic acid is produced, according to Roche's Web site.

Although other plants also contain shikimic acid, star anise has a concentration that makes it particularly attractive to drug manufacturers.

"There are a number of different varieties of star anise, but only one in particular has the concentration of shikimic acid that can be extracted cost-effectively, and I know that we're not concerned about that supply," said Al Wasilewski, a spokesperson for Roche in Nutley, New Jersey, to National Geographic.

Roche also produces shikimic acid using an alternative, E. coli bacteria-fermentation process. Roche hopes to expand the use of this process to make harvesting shikimic acid more cost-effective, thereby reducing demand for star anise.

"About a third of our production of shikimic acid comes from fermentation, and our goal over time is to shift from an extraction-dominant [star anise-based] source of shikimic acid to a fermentation source," Wasilewski reportedly said.

Meanwhile, there is no short-term supply relief in sight, as star anise trees take years to mature. However, Deep notes that star anise is still commercially available, albeit at a high price, and that such markets are always subject to unpredictable events.

"If the world is fortunate with this pandemic that everyone is talking about, the whole demand for Tamiflu may just go down the tubes," he said.

"Star anise has found its day in the sun-but how long it will last is anyone's guess."

Source:
Bird-Flu Fears Spur Sales of Star Anise Spice, National Geographic online, 29 November 2005.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
September 4, 2008
Audience: Rheumatological, gastroenterological and infectious disease healthcare professionals[Posted 09/04/2008] FDA notified...
September 1, 2008
Audience: Emergency healthcare professionals, military emergency/disaster/field hospital/aviation personnel [Posted 08/28/2008]...
August 25, 2008
Audience: Neurologists, other healthcare professionals, patients[Posted 08/25/2008] FDA informed healthcare professionals of two...
August 21, 2008
Audience: Endocrinologists, cardiologists, other healthcare professionals, patients[Posted 08/21/2008] FDA informed healthcare...
More...
Latest Drug Information Updates

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

More...